Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Plasma Therapy for Diverse Wounds

NCT: NCT07553689 · NOT_YET_RECRUITING

NCT IDNCT07553689
StatusNOT_YET_RECRUITING
Start Date2026-05-01
Completion2029-12-31

Brief Summary

This study is a prospective, multicenter, real-world observational study. It aims to evaluate whether adding plasma device therapy to standard wound care is effective and safe for treating different types of wounds, including acute wounds (such as burns and surgical incisions), chronic wounds (such as diabetic foot ulcers and pressure injuries), post-grafting wounds, and sutured wounds. A total of 500 patients receiving standard wound care plus plasma therapy will be enrolled from multiple hospitals across China. Their outcomes will be compared with 500 matched patients who received standard wound care alone. The main outcomes include wound healing rate at 4 weeks, time to complete wound closure, pain relief, scar formation, and any side effects. Patients will be followed for up to 6 months.

Frequently Asked Questions

What is Plasma Therapy for Diverse Wounds?

Plasma Therapy for Diverse Wounds is a clinical trial registered under NCT07553689. Current status: NOT_YET_RECRUITING.

What is the status of NCT07553689?

The current status of NCT07553689 (Plasma Therapy for Diverse Wounds) is: NOT_YET_RECRUITING.

When did Plasma Therapy for Diverse Wounds start?

Plasma Therapy for Diverse Wounds started on 2026-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.